TRPM3

Chr 9AD

transient receptor potential cation channel subfamily M member 3

Also known as: CTRCT50, GON-2, LTRPC3, MLSN2, NEDFSS

This gene encodes a constitutively active calcium channel that mediates calcium entry into cells and functions in heat sensing, pain sensitivity, and insulin secretion. Mutations cause autosomal dominant neurodevelopmental disorder with hypotonia, dysmorphic features, and skeletal anomalies with or without seizures, as well as cataract with or without glaucoma. The gene is highly constrained against loss-of-function variants (LOEUF 0.453), indicating that such mutations are likely pathogenic.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismADLOEUF 0.452 OMIM phenotypes
Clinical SummaryTRPM3
🧬
Gene-Disease Validity (ClinGen)
syndromic complex neurodevelopmental disorder · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.33) despite low pLI — interpret in context.
📋
ClinVar Variants
19 unique Pathogenic / Likely Pathogenic· 220 VUS of 316 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — TRPM3
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint
0.45LOEUF
pLI 0.000
Z-score 5.64
OE 0.33 (0.240.45)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
3.18Z-score
OE missense 0.72 (0.670.76)
716 obs / 998.5 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.33 (0.240.45)
00.351.4
Missense OE0.72 (0.670.76)
00.61.4
Synonymous OE0.99
01.21.6
LoF obs/exp: 27 / 82.2Missense obs/exp: 716 / 998.5Syn Z: 0.13
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveTRPM3-related developmental disorderOTHERAD
DN
0.6938th %ile
GOF
0.73top 25%
LOF
0.3455th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFGain-of-function variants in the ion channel gene TRPM3 underlie a spectrum of neurodevelopmental disorders.PMID:36648066

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

316 submitted variants in ClinVar

Classification Summary

Pathogenic14
Likely Pathogenic5
VUS220
Likely Benign35
Benign15
Conflicting5
14
Pathogenic
5
Likely Pathogenic
220
VUS
35
Likely Benign
15
Benign
5
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
14
0
14
Likely Pathogenic
1
2
2
0
5
VUS
9
202
8
1
220
Likely Benign
0
13
4
18
35
Benign
0
4
3
8
15
Conflicting
5
Total102213127294

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TRPM3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →